GSK and SPRO Related Headlines
Go Back- Spero and GSK report positive phase 3 trial for oral antibiotic
- PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
